Efficacy and safety of chloroquine plus prednisone for the treatment of autoimmune hepatitis in a randomized trial

BACKGROUND AND AIM: Standard treatment for autoimmune hepatitis (AIH) consists of predniso(lo)ne and azathioprine. However, alternative therapy is required for non‐ or partial responders and in cases of side effects. The aim of this study was to evaluate the treatment outcomes associated with chloro...

Descripción completa

Detalles Bibliográficos
Autores principales: T de Moraes Falcão, Lydia, Terrabuio, Debora R B, Diniz, Marcio A, da Silva Evangelista, Andreia, Souza, Fabricio G, R Cancado, Eduardo L
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Wiley Publishing Asia Pty Ltd 2019
Materias:
Original Articles
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273702/
https://www.ncbi.nlm.nih.gov/pubmed/32514439
http://dx.doi.org/10.1002/jgh3.12258

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7273702/
https://www.ncbi.nlm.nih.gov/pubmed/32514439
http://dx.doi.org/10.1002/jgh3.12258

Ejemplares similares